BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:With recent advancements into Phase II and III trials for pers
 onalized cancer vaccines along with 437 other candidates in development\,
  the biopharma industry is at a critical point to demonstrate safe and ef
 ficacious results that will offer a real hope for every patient with a cu
 re for cancer.\n\nThe Personalized Cancer Vaccine Summit (formerly known 
 as the mRNA Cancer Vaccine Summit) returns to Boston for the third year b
 ringing together the top industry players developing individualized appro
 aches across several modalities including mRNA\, DNA\, peptides\, viral\,
  dendritic cell and more to share how they are conquering common challeng
 es\, developing novel bioinformatic strategies\, and achieving clinical e
 fficacy.\n\nJoin the likes of BioNTech\, CureVac\, Imvax\, NousCom and 80
 + key stakeholders at the ultimate learning and networking forum to help 
 you and your teams advance your patient-centric pipelines towards the cli
 nic and regulatory approval.\n\n \n\nTime: 8:00 AM - 5:00 PM\n
DTEND:20241205T170000
DTSTAMP:20260512T233308Z
DTSTART:20241203T080000
LOCATION:Hilton Boston Back Bay\, 40\, Dalton Street\, Boston\, Massachuse
 tts\, 02115\,
SEQUENCE:0
SUMMARY:With recent advancements into Phase II and III trials for personal
 ized cancer vaccines along with 437 other candidates in development\, the
  biopharm...
UID:37b793b0-7df8-48c6-8f34-4d3a52e6cece
END:VEVENT
END:VCALENDAR